Ocular Hypertension
Showing NaN - NaN of 23
Open-angle Glaucoma, Ocular Hypertension Trial in Japan, United States (AGN-193408 SR, Lumigan, Sham Administration)
Recruiting
- Open-angle Glaucoma
- Ocular Hypertension
- AGN-193408 SR
- +3 more
-
Inglewood, California
- +27 more
Oct 4, 2022
Glaucoma, Open-Angle, Ocular Hypertension Trial in United States (Test - Bimatoprost 0.01% Ophthalmic Solution, Reference -
Recruiting
- Glaucoma, Open-Angle
- Ocular Hypertension
- Test - Bimatoprost 0.01% Ophthalmic Solution
- Reference - LUMIGAN® (Bimatoprost 0.01% Ophthalmic Solution)
-
Newport Beach, California
- +8 more
Aug 9, 2022
Open-Angle Glaucoma, Ocular Hypertension Trial in United States (Bimatoprost SR, LUMIGAN)
Completed
- Open-Angle Glaucoma
- Ocular Hypertension
- Bimatoprost SR
- LUMIGAN
-
Dothan, Alabama
- +5 more
May 17, 2022
Open Angle Glaucoma, Ocular Hypertension Trial in United States (OTX-TIC low dose Travoprost Intracameral Implant, OTX-TIC high
Recruiting
- Open Angle Glaucoma
- Ocular Hypertension
- OTX-TIC low dose Travoprost Intracameral Implant
- +2 more
-
Delray Beach, Florida
- +8 more
Apr 12, 2022
Open Angle Glaucoma, Ocular Hypertension Trial in United States (Brimonidine Tartrate Ophthalmic Suspension, Brimonidine
Completed
- Open Angle Glaucoma
- Ocular Hypertension
- Brimonidine Tartrate Ophthalmic Suspension
- Brimonidine Tartrate Ophthalmic Solution
-
Chandler, Arizona
- +46 more
Jan 27, 2022
Primary Open Angle Glaucoma, Ocular Hypertension Trial in United States (DE-126 Ophthalmic Solution 0.002% QD, Timolol Maleate
Completed
- Primary Open Angle Glaucoma
- Ocular Hypertension
- DE-126 Ophthalmic Solution 0.002% QD
- Timolol Maleate Ophthalmic Solution 0.5% BID
-
Chandler, Arizona
- +40 more
Feb 10, 2022
Ocular Hypertension, Open Angle Glaucoma Trial in United States (OTX-TIC)
Active, not recruiting
- Ocular Hypertension
- Open Angle Glaucoma
-
Petaluma, California
- +4 more
Jun 9, 2021
Ocular Hypertension, Primary Open Angle Glaucoma Trial in United States (Latanoprost ophthalmic solution, AKB-9778, Placebo)
Completed
- Ocular Hypertension
- Primary Open Angle Glaucoma
- Latanoprost ophthalmic solution
- +2 more
-
Inglewood, California
- +20 more
Jan 13, 2021
Glaucoma, Ocular Hypertension Trial in United States (RKI983A, Latanoprost)
Completed
- Glaucoma
- Ocular Hypertension
-
Artesia, California
- +28 more
Dec 11, 2020
Glaucoma, Open-Angle, Ocular Hypertension Trial in United States (Netarsudil Ophthalmic Solution 0.02%)
Completed
- Glaucoma, Open-Angle
- Ocular Hypertension
- Netarsudil Ophthalmic Solution 0.02%
-
Huntington Beach, California
- +21 more
Sep 8, 2020
Glaucoma, Open-Angle, Ocular Hypertension Trial in Worldwide (Bimatoprost SR, Active Comparator: Timolol 0.5%, Sham: Applicator
Completed
- Glaucoma, Open-Angle
- Ocular Hypertension
- Bimatoprost SR
- +3 more
-
Phoenix, Arizona
- +105 more
May 29, 2020
Glaucoma, Open-angle, Ocular Hypertension Trial in United States (0.01% RO7058584, 0.1% RO7058584, 1% RO7058584)
Completed
- Glaucoma, Open-angle
- Ocular Hypertension
- 0.01% RO7058584
- +4 more
-
Chandler, Arizona
- +7 more
Mar 27, 2020
Open-Angle Glaucoma, Ocular Hypertension Trial in Worldwide (bimatoprost 20 µg generation 2, bimatoprost 15 µg generation 2,
Completed
- Open-Angle Glaucoma
- Ocular Hypertension
- bimatoprost 20 µg generation 2
- +6 more
-
Artesia, California
- +56 more
Mar 27, 2020
Open Angle Glaucoma, Ocular Hypertension Trial in United States (PG324 Ophthalmic Solution 0.01%, PG324 Ophthalmic Solution
Completed
- Open Angle Glaucoma
- Ocular Hypertension
- PG324 Ophthalmic Solution 0.01%
- +3 more
-
Artesia, California
- +22 more
May 14, 2019
Open-angle Glaucoma, Ocular Hypertension Trial in United States (DE-117 Low Dose ophthalmic solution, DE-117 Low/Middle Dose
Completed
- Open-angle Glaucoma
- Ocular Hypertension
- DE-117 Low Dose ophthalmic solution
- +5 more
-
Chandler, Arizona
- +13 more
Apr 16, 2018
Ocular Hypertension, Open Angle Glaucoma Trial in United States (AR-13324 Ophthalmic Solution 0.01%, AR-13324 Ophthalmic
Completed
- Ocular Hypertension
- Open Angle Glaucoma
- AR-13324 Ophthalmic Solution 0.01%
- +3 more
-
Newport Beach, California
- +10 more
Mar 19, 2018
Ocular Hypertension, Open Angle Glaucoma Trial in United States (AR-13324 Ophthalmic Solution 0.01%, AR-13324 Ophthalmic
Completed
- Ocular Hypertension
- Open Angle Glaucoma
- AR-13324 Ophthalmic Solution 0.01%
- +2 more
-
Artesia, California
- +21 more
Mar 19, 2018
Ocular Hypertension, Open Angle-glaucoma Trial in United States (ONO-9054, Latanoprost)
Completed
- Ocular Hypertension
- Open Angle-glaucoma
-
Los Angeles, California
- +11 more
Jan 26, 2016
Glaucoma, Ocular Hypertension Trial in United States (Latanoprost 0.005%, AR-12286 Ophthalmic Solution 0.5%, Timolol maleate
Completed
- Glaucoma
- Ocular Hypertension
- Latanoprost 0.005%
- +2 more
-
New Haven, Connecticut
- +14 more
Apr 18, 2014
Open Angle Glaucoma, Ocular Hypertension Trial in United States (PG286 Ophthalmic Solution 0.5%, AR-12286 Ophthalmic Solution
Completed
- Open Angle Glaucoma
- Ocular Hypertension
- PG286 Ophthalmic Solution 0.5%
- +2 more
-
Artesia, California
- +20 more
Feb 17, 2014
Primary Open-angle Glaucoma, Ocular Hypertension Trial in United States (OPA-6566, Placebo, Latanoprost)
Completed
- Primary Open-angle Glaucoma
- Ocular Hypertension
- OPA-6566
- +2 more
-
Artesia, California
- +8 more
Feb 7, 2014
Glaucoma, Open-Angle, Ocular Hypertension Trial in United States (OT-730 ophthalmic solution, timolol maleate ophthalmic
Completed
- Glaucoma, Open-Angle
- Ocular Hypertension
- OT-730 ophthalmic solution
- +2 more
-
Artesia, California
- +4 more
Jan 6, 2009